Table 3.
Reporting of sexual activity, sexual dissatisfaction, and BC decreased their sexual activity frequency in relation to comorbid chronic diseases
Comorbidity | Total | Sexual activity | Sexual dissatisfaction | BC decreased their sexual activity frequency | ||||||
---|---|---|---|---|---|---|---|---|---|---|
N (%) | P a | AOR | N (%) | P a | AOR | N (%) | P a | AOR | ||
Hypertension | ||||||||||
No | 247 (72.4%) | 66 (26.7) | Ref | 59 (23.9) | Ref | 142 (57.5) | Ref | |||
Yes | 94 (27.6%) | 17 (18.1) | .097 | 0.59 (0.29, 1.17) | 22 (23.4) | .926 | 1.23 (0.62, 2.43) | 59 (62.8) | .376 | 1.46 (0.83, 2.58) |
Hyperlipidemia | ||||||||||
No | 239 (70.1%) | 63 (26.4) | Ref | 61 (25.5) | Ref | 143 (59.8) | Ref | |||
Yes | 102 (29.9%) | 20 (19.6) | .183 | 0.71 (0.35, 1.43) | 20 (19.6) | .24 | 0.71 (0.35, 1.45) | 58 (56.9) | .61 | 0.88 (0.49, 1.56) |
Hyperuricemia | ||||||||||
No | 325 (95.3%) | 82 (25.2) | Ref | 75 (23.1) | Ref | 193 (59.4) | Ref | |||
Yes | 16 (4.7%) | 1 (6.3) | .084 | 0.21 (0.02, 1.71) | 6 (37.5) | .186 | 1.97 (0.61, 6.42) | 8 (50.0) | .456 | 0.65 (0.22, 1.95) |
Diabetes mellitus | ||||||||||
No | 307 (90.0%) | 81 (26.4) | Ref | 68 (22.2) | Ref | 182 (59.3) | Ref | |||
Yes | 34 (10.0%) | 2 (5.9) | .008 | 0.18 (0.04, 0.83) | 13 (38.2) | .036 | 2.92 (1.25, 6.79) | 19 (55.9) | .702 | 0.90 (0.41, 1.95) |
Heart and cardiovascular | ||||||||||
No | 298 (87.4%) | 71 (23.8) | Ref | 69 (23.2) | Ref | 171 (57.4) | Ref | |||
Yes | 43 (12.6%) | 12 (27.9) | .559 | 1.70 (0.75, 3.88) | 12 (27.9) | .494 | 1.61 (0.72, 3.63) | 30 (69.8) | .123 | 2.05 (0.96, 4.39) |
Stroke | ||||||||||
No | 334 (98.0%) | 81 (24.3) | Ref | 78 (23.4) | Ref | 196 (58.7) | Ref | |||
Yes | 7 (2.1%) | 2 (28.6) | .792 | 1.84 (0.33, 10.12) | 3 (42.9) | .23 | 3.18 (0.65, 15.58) | 5 (71.4) | .497 | 1.75 (0.32, 9.48) |
Respiratory diseases | ||||||||||
No | 309 (90.6%) | 74 (24.0) | Ref | 76 (24.6) | Ref | 182 (58.9) | Ref | |||
Yes | 32 (9.4%) | 9 (28.1) | .6 | 1.47 (0.59, 3.66) | 5 (15.6) | .256 | 0.54 (0.19, 1.54) | 19 (59.4) | .958 | 1.08 (0.49, 2.41) |
Digestive diseases | ||||||||||
No | 186 (54.6%) | 43 (23.1) | Ref | 49 (26.3) | Ref | 115 (61.8) | Ref | |||
Yes | 155 (45.5%) | 40 (25.8) | .565 | 1.20 (0.61, 2.40) | 32 (20.7) | .218 | 0.88 (0.43, 1.78) | 86 (55.5) | .236 | 0.67 (0.37, 1.21) |
Musculoskeletal diseases | ||||||||||
No | 291 (85.3%) | 71 (24.4) | Ref | 66 (22.7) | Ref | 175 (60.1) | Ref | |||
Yes | 50 (14.7%) | 12 (24.0) | .952 | 1.23 (0.55,2.79) | 15 (30.0) | .261 | 1.81 (0.83,3.93) | 26 (52.0) | .279 | 0.71 (0.36,1.41) |
Number of comorbidity | ||||||||||
0‐1 | 184 (53.9%) | 53 (28.8) | Ref | 41 (22.3) | Ref | 112 (60.9) | Ref | |||
2‐3 | 125 (36.7%) | 24 (19.2) | 0.83 (0.45, 1.53) | 31 (24.8) | 1.17 (0.65, 2.11) | 71 (56.8) | 0.93 (0.57, 1.54) | |||
≥4 | 32 (9.4%) | 6 (18.8) | .115 | 0.91 (0.33, 2.47) | 9 (28.1) | .729 | 1.56 (0.64, 3.85) | 18 (56.3) | .735 | 1.05 (0.47, 2.33) |
All models were adjusted for age, marital status, self‐reported general health status, and time since cancer diagnosis.
Models investigating each specific comorbid chronic disease were also adjusted for the number of comorbidity.
Bold face P < .05.
Abbreviations: AOR, adjusted odds ratio; BC, breast cancer.
Chi‐square test or Fisher's exact test.